These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9012641)

  • 1. Apolipoprotein A-IFin. Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene.
    Miettinen HE; Gylling H; Miettinen TA; Viikari J; Paulin L; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):83-90. PubMed ID: 9012641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
    Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A-I(Zavalla) (Leu159-->Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease.
    Miller M; Aiello D; Pritchard H; Friel G; Zeller K
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1242-7. PubMed ID: 9714130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.
    Lackner KJ; Dieplinger H; Nowicka G; Schmitz G
    J Clin Invest; 1993 Nov; 92(5):2262-73. PubMed ID: 7693760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano.
    Bruckert E; von Eckardstein A; Funke H; Beucler I; Wiebusch H; Turpin G; Assmann G
    Atherosclerosis; 1997 Jan; 128(1):121-8. PubMed ID: 9051205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of apolipoprotein A-I, lecithin:cholesterol acyltransferase and glucocerebrosidase genes in hypoalphalipoproteinemia.
    Recalde D; Cenarro A; García-Otín AL; Gómez-Coronado D; Civeira F; Pocoví M
    Atherosclerosis; 2002 Jul; 163(1):49-58. PubMed ID: 12048121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease.
    Miccoli R; Bertolotto A; Navalesi R; Odoguardi L; Boni A; Wessling J; Funke H; Wiebusch H; Eckardstein A; Assmann G
    Circulation; 1996 Oct; 94(7):1622-8. PubMed ID: 8840853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent occurrence of hypoalphalipoproteinemia due to mutant apolipoprotein A-I gene in the population: a population-based survey.
    Yamakawa-Kobayashi K; Yanagi H; Fukayama H; Hirano C; Shimakura Y; Yamamoto N; Arinami T; Tsuchiya S; Hamaguchi H
    Hum Mol Genet; 1999 Feb; 8(2):331-6. PubMed ID: 9931341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization.
    Marcil M; Boucher B; Krimbou L; Solymoss BC; Davignon J; Frohlich J; Genest J
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1015-24. PubMed ID: 7627690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal dominant hypoalphalipoproteinemia due to a completely defective apolipoprotein A-I gene.
    Nakata K; Kobayashi K; Yanagi H; Shimakura Y; Tsuchiya S; Arinami T; Hamaguchi H
    Biochem Biophys Res Commun; 1993 Oct; 196(2):950-5. PubMed ID: 8240372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.
    Ng DS; Leiter LA; Vezina C; Connelly PW; Hegele RA
    J Clin Invest; 1994 Jan; 93(1):223-9. PubMed ID: 8282791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia.
    Pisciotta L; Fasano T; Calabresi L; Bellocchio A; Fresa R; Borrini C; Calandra S; Bertolini S
    Atherosclerosis; 2008 May; 198(1):145-51. PubMed ID: 17950741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia.
    Roma P; Gregg RE; Meng MS; Ronan R; Zech LA; Franceschini G; Sirtori CR; Brewer HB
    J Clin Invest; 1993 Apr; 91(4):1445-52. PubMed ID: 8473493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygosity for an apolipoprotein A1 gene promoter mutation and a structural nonsense mutation with apolipoprotein A1 deficiency.
    Matsunaga A; Sasaki J; Han H; Huang W; Kugi M; Koga T; Ichiki S; Shinkawa T; Arakawa K
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):348-55. PubMed ID: 9974418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations.
    Jeenah M; Kessling A; Miller N; Humphries S
    Mol Biol Med; 1990 Jun; 7(3):233-41. PubMed ID: 1977072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gene causing familial hypoalphalipoproteinemia is not caused by a defect in the apo AI-CIII-AIV gene cluster in a Spanish family.
    Kastelein JJ; Haines JL; Hayden MR
    Hum Genet; 1990 Apr; 84(5):396-400. PubMed ID: 1969839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cysteine-containing truncated apo A-I variant associated with HDL deficiency.
    Moriyama K; Sasaki J; Takada Y; Matsunaga A; Fukui J; Albers JJ; Arakawa K
    Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1416-23. PubMed ID: 8977444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutant, ApoA-I nichinan (Glu235-->0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells.
    Han H; Sasaki J; Matsunaga A; Hakamata H; Huang W; Ageta M; Taguchi T; Koga T; Kugi M; Horiuchi S; Arakawa K
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1447-55. PubMed ID: 10364075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of two new human apolipoprotein A-I variants: apolipoprotein A-I Tsushima (Trp-108-->Arg) and A-I Hita (Ala-95-->Asp).
    Araki K; Sasaki J; Matsunaga A; Takada Y; Moriyama K; Hidaka K; Arakawa K
    Biochim Biophys Acta; 1994 Oct; 1214(3):272-8. PubMed ID: 7918609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.